Targeting interleukin 18 with interleukin 18 binding protein

Annals of the Rheumatic Diseases

Volumn 59, Issue SUPPL. 1, 2000, Pages

  Dinarello, C A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTERLEUKIN 18; ISOPROTEIN;

BINDING AFFINITY; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; IMMUNOPATHOLOGY; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN TARGETING; RHEUMATIC DISEASE; SEPTIC SHOCK; THERAPY;

EID: 0033758410     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.suppl_1.i17     Document Type: Conference Paper

References (27)

1. Acquisition of lymphokine-producing phenotype by CD4+ T cells
2. Endotoxin-induced serum factor that stimulates gamma inteferon production
3. Defective NK cell activity and Th1 response in IL-18-deficient mice
4. IL-12 upregulates IL-18 receptor expression on T cells, Th1 cells and B cells: Synergism with IL-18 for IFNγ production
5. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
6. Purification and characterization of the human interleukin-18 receptor
7. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response
8. Structural requirements of six naturally occurring isoforms of the interleukin-18 binding protein to inhibit interleukin-18
9. An efficient directional cloning system to construct cDNA libraries containing full -length inserts at hight frequency
10. A newly defined interleukin-1?
11. Crystal structure of the type I interleukin-1 receptor complexed with interleukin-1β
12. An antibody to a 17 amino acid synthetic peptide to the IL-1RI preferentially blocks IL-1β binding
13. Binding of IL-1α IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids
14. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta
15. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
16. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins
17. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1
18. Cutting edge: Generation of IL-18 receptor-deficient mice - Evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor
19. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia
20. Leptin-deficient (ob/ob) mice are protected from t cell-mediated hepatotoxicity: Role of tumor necrosis factor alpha and IL-18
21. IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma
22. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
23. Modulation of helper T cell function by prostaglandins
24. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses
25. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness
26. Prostaglandin E2 primes naive T cells for the production of anti- inflammatory cytokines
27. Gene expression, synthesis and secretion of IL-1β and IL-18 are differentially regulated in human blood mononuclear cells and mouse spleen cells